Therapeutic antimicrobial agents should ideally be pathogen-directed to minimize resistance, side effects, and treatment failure. Once the causative pathogen and its antimicrobial susceptibilities are known, the most narrow-spectrum, effective agent should be used.
Why the Other Options Are Incorrect?
A. The infecting agent is unknown – Empiric therapy may be necessary initially, but definitive therapy should be based on pathogen identification.
B. The patient's illness warrants treatment prior to culture results – This applies to empiric therapy, but not to definitive antimicrobial selection.
C. The patient’s symptoms suggest likely pathogens – Clinical presentation guides empiric treatment, but definitive therapy should follow culture and susceptibility testing.
CBIC Infection Control Reference
APIC emphasizes the importance of selecting antimicrobials based on pathogen identification and susceptibility testing to prevent antimicrobial resistance.